Robust Generation of Lead Compounds for Protein–Protein Interactions by Computational and MCR Chemistry: p53/Hdm2 Antagonists
Authors:
- Anna CzarnaACAnna Czarna
- Grzegorz M. PopowiczGPGrzegorz M. Popowicz
- Siglinde WolfSWSiglinde Wolf
- Michal BistaMBMichal Bista
- Tad A. HolakTHTad A. Holak
- Alexander DömlingADAlexander Dömling
- 16 July 2010
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 49 (31) , 5352-5356
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discoveryNucleic Acids Research, 2010
- Identification and Characterization of the First Small Molecule Inhibitor of MDMXJournal of Biological Chemistry, 2010
- Strategies for Innovation in Multicomponent Reaction DesignAccounts of Chemical Research, 2009
- Applications of Multicomponent Reactions to the Synthesis of Diverse Heterocyclic ScaffoldsChemistry – A European Journal, 2009
- Perspectives on NMR in drug discovery: a technique comes of ageNature Reviews Drug Discovery, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Exploration of liquid and supercritical fluid chromatographic chiral separation and purification of Nutlin-3—A small molecule antagonist of MDM2Journal of Pharmaceutical and Biomedical Analysis, 2007
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in CellsJournal of Medicinal Chemistry, 2005
- Anatomy of hot spots in protein interfacesJournal of Molecular Biology, 1998